China's Sirio Healthcare Products Face Automatic Detention, 45 Items Detained as of September 17
Recently, the US Food and Drug Administration (FDA) issued updated import alert measures on its official website, automatically withholding products from a Chinese company. The details are as follows:
| Warning Number |
Release Date |
Region |
Company Name |
Product Name |
Project |
| Feb-45 |
2024/9/17 |
Anhui, Ma'anshan |
Sirio Healthcare (Anhui) Co., Ltd |
Pectin Gummies (2g gummies containing 1mg Melatonin) |
Anthocyanins |
An import alert is a preventive measure taken by the FDA against imported foods that may pose a potential risk when they enter the U.S. market. For those companies or products that trigger import alert conditions, the FDA will perform an automatic Detention Without Physical Examination (DWPE). To be clear, automatic detention does not equate to a determination that an export does not comply with U.S. import regulations. For automatically detained goods, they must be inspected by FDA or its authorized laboratory and reviewed and approved by the local FDA branch before customs will allow them to be released and then sold in the U.S. market.
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
Rare Earth and Power: Strategic Probing Beneath the New U.S.–China Trade Framework
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
Recommend Reading
-
Chemical Tanker Explodes Off Oman Coast, Maritime Security Risk Escalates Again
-
SK Chemicals Partners with China’s Kelinle to Build Its Own Waste-Plastic Supply Network
-
Eastern Shenghong Projects First-Half Profit of 5 Billion Yuan – A Collective Turnaround for the Four Major Private Refiners? Is the Chemical Sector Rebounding?
-
Tinci Materials Calls Off 2.65 Billion Yuan Project as Electrolyte Giant Shifts Strategy
-
Chung Lien Oil’s 8,000-Ton Soybean Oil BaP Scandal: NT$165 Million Fine, 401 Product Recalls, Source Still Unknown
-
Moving Average Bearish Signal Strengthens—Acrylic Still Has Downside Potential in the Future
-
Insufficient Positive Factors, This Week's Cyclohexanone Market in Shandong Narrowly Decreased
-
Rally and Retreat! Epichlorohydrin Falls Back to 10,000 Yuan per Ton
-
This week, the Chinese anhydrous hydrogen fluoride market remains stable (11.3-11.6)
-
Bullish Support, Hydrogen Peroxide Prices Oscillate and Rise in China